Skip to main content
Erschienen in: Urolithiasis 5/2017

19.10.2016 | Original Paper

Comparative risk of chronic kidney diseases in patients with urolithiasis and urological interventions: a longitudinal population-based study

verfasst von: Shih-Yi Lin, Cheng-Li Lin, Chao-Hsiang Chang, His-Chin Wu, Wen-Chi Chen, I-Kuan Wang, Yao Lung Liu, Fung-Chang Sung, Yen-Jung Chang, Chia-Hung Kao

Erschienen in: Urolithiasis | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Large cohort studies on whether any association existed between urological interventions for urolithiasis and the development of CKD are lacking. From claims data of the National Health Insurance (NHI) program of Taiwan, we identified 54,433 patients newly diagnosed with urolithiasis during 1998–2010. For each case, four individuals without urolithiasis were randomly selected and frequency matched by age, sex, and diagnosis year. Both groups were followed up until the end of 2010. Incident CKD events were identified by the International Classification of Diseases, Ninth Revision (ICD-9) code in the NHI registration database. The overall incidence of periodontal diseases was 1.85-fold greater in the urolithiasis group than in the comparison group (33.9 vs 18.3 per 10,000 person-years; 95 % confidence interval [CI] 1.81–1.90). Compared with the adjusted hazard ratios (aHRs) of nonurolithiasis patients, those of patients with urolithiasis increased with the number of medical visits (from 0.91 [95 % CI 0.83–1.00] to 10.6 [95 % CI 9.48–11.8]) and urological interventions (from 1.22 [95 % CI 1.10–1.35] to 86.4 [95 % CI 67.6–110.6]). The aHR was similar in different urological intervention methods, extracorporeal shock wave lithotripsy, ureteroscopy, percutaneous nephrostolithotomy, and open stone surgery. The urological intervention for urolithiasis is associated with an increased risk of CKD. We should be aware of the risk for CKD, especially in patients who have received multiple urological interventions and those elderly.
Literatur
1.
Zurück zum Zitat Yasui T, Iguchi M, Suzuki S, Kohri K (2008) Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology 71(2):209–213CrossRefPubMed Yasui T, Iguchi M, Suzuki S, Kohri K (2008) Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology 71(2):209–213CrossRefPubMed
2.
Zurück zum Zitat Safarinejad MR (2007) Adult urolithiasis in a population-based study in Iran: prevalence, incidence, and associated risk factors. Urol Res 35(2):73–82CrossRefPubMed Safarinejad MR (2007) Adult urolithiasis in a population-based study in Iran: prevalence, incidence, and associated risk factors. Urol Res 35(2):73–82CrossRefPubMed
3.
Zurück zum Zitat Hesse A, Brändle E, Wilbert D, Köhrmann K-U, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44(6):709–713CrossRefPubMed Hesse A, Brändle E, Wilbert D, Köhrmann K-U, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 44(6):709–713CrossRefPubMed
4.
Zurück zum Zitat Knoll T (2010) Epidemiology, pathogenesis, and pathophysiology of urolithiasis. Eur Urol Suppl 9(12):802–806CrossRef Knoll T (2010) Epidemiology, pathogenesis, and pathophysiology of urolithiasis. Eur Urol Suppl 9(12):802–806CrossRef
5.
Zurück zum Zitat Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci 105(28):9841–9846CrossRefPubMedPubMedCentral Brikowski TH, Lotan Y, Pearle MS (2008) Climate-related increase in the prevalence of urolithiasis in the United States. Proc Natl Acad Sci 105(28):9841–9846CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Fink HA, Akornor JW, Garimella PS, MacDonald R, Cutting A, Rutks IR, Monga M, Wilt TJ (2009) Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol 56(1):72–80CrossRefPubMedPubMedCentral Fink HA, Akornor JW, Garimella PS, MacDonald R, Cutting A, Rutks IR, Monga M, Wilt TJ (2009) Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol 56(1):72–80CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Pearle MS, Calhoun EA, Curhan GC, Project UDoA (2005) Urologic diseases in America project: urolithiasis. J Urol 173(3):848–857CrossRefPubMed Pearle MS, Calhoun EA, Curhan GC, Project UDoA (2005) Urologic diseases in America project: urolithiasis. J Urol 173(3):848–857CrossRefPubMed
8.
Zurück zum Zitat Skolarikos A, Alivizatos G, de la Rosette J (2006) Extracorporeal shock wave lithotripsy 25 years later: complications and their prevention. Eur Urol 50(5):981–990CrossRefPubMed Skolarikos A, Alivizatos G, de la Rosette J (2006) Extracorporeal shock wave lithotripsy 25 years later: complications and their prevention. Eur Urol 50(5):981–990CrossRefPubMed
9.
Zurück zum Zitat Paryani JP, Ather MH (2002) Improvement in serum creatinine following definite treatment of urolithiasis in patients with concurrent renal insufficiency. Scand J Urol Nephrol 36(2):134–136CrossRefPubMed Paryani JP, Ather MH (2002) Improvement in serum creatinine following definite treatment of urolithiasis in patients with concurrent renal insufficiency. Scand J Urol Nephrol 36(2):134–136CrossRefPubMed
10.
Zurück zum Zitat Lifshitz DA, Lingeman JE, Zafar FS, Hollensbe DW, Nyhuis AW, Evan AP (1998) Alterations in predicted growth rates of pediatric kidneys treated with extracorporeal shockwave lithotripsy. J Endourol Soc 12(5):469–475CrossRef Lifshitz DA, Lingeman JE, Zafar FS, Hollensbe DW, Nyhuis AW, Evan AP (1998) Alterations in predicted growth rates of pediatric kidneys treated with extracorporeal shockwave lithotripsy. J Endourol Soc 12(5):469–475CrossRef
11.
Zurück zum Zitat Willis LR, Evan AP, Connors BA, Blomgren P, Fineberg NS, Lingeman JE (1999) Relationship between kidney size, renal injury, and renal impairment induced by shock wave lithotripsy. J Am Soc Nephrol CJASN 10(8):1753–1762 Willis LR, Evan AP, Connors BA, Blomgren P, Fineberg NS, Lingeman JE (1999) Relationship between kidney size, renal injury, and renal impairment induced by shock wave lithotripsy. J Am Soc Nephrol CJASN 10(8):1753–1762
12.
Zurück zum Zitat Goel MC, Baserge NS, Babu RV, Sinha S, Kapoor R (1996) Pediatric kidney: functional outcome after extracorporeal shock wave lithotripsy. J Urol 155(6):2044–2046CrossRefPubMed Goel MC, Baserge NS, Babu RV, Sinha S, Kapoor R (1996) Pediatric kidney: functional outcome after extracorporeal shock wave lithotripsy. J Urol 155(6):2044–2046CrossRefPubMed
13.
Zurück zum Zitat Traxer O, Lottmann H, Archambaud F, Helal B, Mercier-Pageyral B (1999) Extracorporeal lithotripsy in children. Study of its efficacy and evaluation of renal parenchymal damage by DMSA-Tc 99 m scintigraphy: a series of 39 children. Arch de pediatrie : organe officiel de la Societe francaise de pediatrie 6(3):251–258CrossRef Traxer O, Lottmann H, Archambaud F, Helal B, Mercier-Pageyral B (1999) Extracorporeal lithotripsy in children. Study of its efficacy and evaluation of renal parenchymal damage by DMSA-Tc 99 m scintigraphy: a series of 39 children. Arch de pediatrie : organe officiel de la Societe francaise de pediatrie 6(3):251–258CrossRef
14.
Zurück zum Zitat El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol CJASN 7(9):1409–1415CrossRefPubMed El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD (2012) Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol CJASN 7(9):1409–1415CrossRefPubMed
15.
Zurück zum Zitat Kummer AE, Grams M, Lutsey P, Chen Y, Matsushita K, Kottgen A, Folsom AR, Coresh J (2015) Nephrolithiasis as a Risk Factor for CKD: The Atherosclerosis Risk in Communities Study. Clin J Am Soc Nephrol CJASN 10(11):2023–2029CrossRefPubMed Kummer AE, Grams M, Lutsey P, Chen Y, Matsushita K, Kottgen A, Folsom AR, Coresh J (2015) Nephrolithiasis as a Risk Factor for CKD: The Atherosclerosis Risk in Communities Study. Clin J Am Soc Nephrol CJASN 10(11):2023–2029CrossRefPubMed
16.
Zurück zum Zitat Gillen DL, Worcester EM, Coe FL (2005) Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 67(2):685–690CrossRefPubMed Gillen DL, Worcester EM, Coe FL (2005) Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 67(2):685–690CrossRefPubMed
17.
Zurück zum Zitat Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56(2):571–580CrossRefPubMed Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Pichler R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE (1999) Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56(2):571–580CrossRefPubMed
18.
Zurück zum Zitat Saucier NA, Sinha MK, Liang KV, Krambeck AE, Weaver AL, Bergstralh EJ, Li X, Rule AD, Lieske JC (2010) Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis 55(1):61–68CrossRefPubMed Saucier NA, Sinha MK, Liang KV, Krambeck AE, Weaver AL, Bergstralh EJ, Li X, Rule AD, Lieske JC (2010) Risk factors for CKD in persons with kidney stones: a case-control study in Olmsted County, Minnesota. Am J Kidney Dis 55(1):61–68CrossRefPubMed
19.
Zurück zum Zitat Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67(5):1739–1742CrossRefPubMed Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ (2005) Hyperuricemia induces endothelial dysfunction. Kidney Int 67(5):1739–1742CrossRefPubMed
20.
Zurück zum Zitat Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Samuel S, Klarenbach SW, Curhan GC, Tonelli M (2014) Kidney stones and cardiovascular events: a cohort study. Clin J Am Soc Nephrol 9(3):506–512CrossRefPubMed Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Samuel S, Klarenbach SW, Curhan GC, Tonelli M (2014) Kidney stones and cardiovascular events: a cohort study. Clin J Am Soc Nephrol 9(3):506–512CrossRefPubMed
21.
Zurück zum Zitat Gambaro G, Favaro S, D’Angelo A (2001) Risk for renal failure in nephrolithiasis. Am J Kidney Dis 37(2):233–243CrossRefPubMed Gambaro G, Favaro S, D’Angelo A (2001) Risk for renal failure in nephrolithiasis. Am J Kidney Dis 37(2):233–243CrossRefPubMed
22.
Zurück zum Zitat Stankus N, Hammes M, Gillen D, Worcester E (2007) African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III. Urol Res 35(2):83–87CrossRefPubMed Stankus N, Hammes M, Gillen D, Worcester E (2007) African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III. Urol Res 35(2):83–87CrossRefPubMed
23.
Zurück zum Zitat Siegel C (2012) Re: Clinical characteristics of potential kidney donors with asymptomatic kidney stones. J Urol 188(3):849–850CrossRefPubMed Siegel C (2012) Re: Clinical characteristics of potential kidney donors with asymptomatic kidney stones. J Urol 188(3):849–850CrossRefPubMed
24.
Zurück zum Zitat Strang AM, Lockhart ME, Amling CL, Kolettis PN, Burns JR (2008) Living renal donor allograft lithiasis: a review of stone related morbidity in donors and recipients. J Urol 179(3):832–836CrossRefPubMed Strang AM, Lockhart ME, Amling CL, Kolettis PN, Burns JR (2008) Living renal donor allograft lithiasis: a review of stone related morbidity in donors and recipients. J Urol 179(3):832–836CrossRefPubMed
25.
Zurück zum Zitat Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Morgan C, Samuel S, Klarenbach SW, Curhan GC, Tonelli M (2012) Kidney stones and kidney function loss: a cohort study. BMJ 345:e5287–e5294CrossRefPubMedPubMedCentral Alexander RT, Hemmelgarn BR, Wiebe N, Bello A, Morgan C, Samuel S, Klarenbach SW, Curhan GC, Tonelli M (2012) Kidney stones and kidney function loss: a cohort study. BMJ 345:e5287–e5294CrossRefPubMedPubMedCentral
Metadaten
Titel
Comparative risk of chronic kidney diseases in patients with urolithiasis and urological interventions: a longitudinal population-based study
verfasst von
Shih-Yi Lin
Cheng-Li Lin
Chao-Hsiang Chang
His-Chin Wu
Wen-Chi Chen
I-Kuan Wang
Yao Lung Liu
Fung-Chang Sung
Yen-Jung Chang
Chia-Hung Kao
Publikationsdatum
19.10.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 5/2017
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-016-0929-y

Weitere Artikel der Ausgabe 5/2017

Urolithiasis 5/2017 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Männern mit Zystitis Schmalband-Antibiotika verordnen

03.05.2024 Zystitis Nachrichten

Die akute Zystitis von Männern und ihre Therapie sind wenig erforscht. Norwegische Forscher haben das nachgeholt. Ihr Rat: Erst einmal keine Breitbandantibiotika verordnen.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.